Evidence map›Paper›PMID 19061901›Full record

ArticleJournal of molecular biology2009

Selecting optimum eukaryotic integral membrane proteins for structure determination by rapid expression and solubilization screening.

Min Li, Franklin A Hays, Zygy Roe-Zurz, Linda Vuong, Libusha Kelly, Chi-Min Ho, Renée M Robbins, Ursula Pieper, Joseph D O'Connell, Larry J W Miercke and 3 more

Open access · greenAbstract read
In one paragraph

Article in Journal of molecular biology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 53 citations in OpenAlex.

  1. Structural basis of disease mutation and substrate recognition by the human SLC2A9 transporter.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  2. Molecular basis of multistep voltage activation in plant two-pore channel 1.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Current strategies for protein production and purification enabling membrane protein structural biology.Biochemistry and cell biology = Biochimie et biologie cellulaire · 2016
    Review
  9. Integral Membrane Protein Expression in Saccharomyces cerevisiae.Methods in molecular biology (Clifton, N.J.) · 2016
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Structural genomics plucks high-hanging membrane proteins.Current opinion in structural biology · 2012
    Review
  17. Article
  18. Review
  19. Article
  20. Unlocking the eukaryotic membrane protein structural proteome.Current opinion in structural biology · 2010
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Min LiMembrane Protein Expression Center, University of California at San Francisco, San Francisco, CA 94158-2517, USA.
Franklin A Hays
Zygy Roe-Zurz
Linda Vuong
Libusha Kelly
Chi-Min Ho
Renée M Robbins
Ursula Pieper
Joseph D O'Connell
Larry J W Miercke
Kathleen M Giacomini
Andrej Sali
Robert M Stroud
Protein Express (United States) · USUniversity of California, San Francisco · USQB3 · US

Funding

PHARMACOGENETICS OF MEMBRANE TRANSPORTERSU01GM061390 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GIACOMINI, KATHLEEN M · 2000 to 2009
$29.2M
Yeast ExpressionP50GM073210 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI STROUD, ROBERT M · 2004 to 2013
$21.5M
SPECIALIZED CENTER FOR THE PROTEIN STRUCTURE INITIATIVEU54GM074929 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI REIK, ROLAND · 2005 to 2009
$16.6M
Molecular Basis for Aquaporin ConductanceF32GM078754 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HAYS, FRANKLIN ALAN · 2006 to 2008
$145k
NIGMS NIH HHS F32 GM078754NIGMS NIH HHS P50 GM073210NIGMS NIH HHS U01 GM061390NIGMS NIH HHS U01 GM61390NIGMS NIH HHS U54 GM074929
6 · The paper itself

Abstract

A medium-throughput approach is used to rapidly identify membrane proteins from a eukaryotic organism that are most amenable to expression in amounts and quality adequate to support structure determination. The goal was to expand knowledge of new membrane protein structures based on proteome-wide coverage. In the first phase, membrane proteins from the budding yeast Saccharomyces cerevisiae were selected for homologous expression in S. cerevisiae, a system that can be adapted to expression of membrane proteins from other eukaryotes. We performed medium-scale expression and solubilization tests on 351 rationally selected membrane proteins from S. cerevisiae. These targets are inclusive of all annotated and unannotated membrane protein families within the organism's membrane proteome. Two hundred seventy-two targets were expressed, and of these, 234 solubilized in the detergent n-dodecyl-beta-D-maltopyranoside. Furthermore, we report the identity of a subset of targets that were purified to homogeneity to facilitate structure determinations. The extensibility of this approach is demonstrated with the expression of 10 human integral membrane proteins from the solute carrier superfamily. This discovery-oriented pipeline provides an efficient way to select proteins from particular membrane protein classes, families, or organisms that may be more suited to structure analysis than others.

Indexed as

Chromatography, AffinityChromatography, GelHumansMembrane ProteinsPlasmidsProtein Sorting SignalsSaccharomyces cerevisiae ProteinsSolubilityMembrane ProteinsProtein Sorting SignalsSaccharomyces cerevisiae Proteins

Identifiers

PMID19061901
PMCPMC2659619
OpenAlexW2147252713

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.